OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN

OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN was reported 12201 times

OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GRIP STRENGTH 102 0.4454
1 DEPENDENCE 18829 0.3431
2 SWOLLEN JOINT COUNT 53 0.2120
3 DRUG WITHDRAWAL SYNDROME NEONATAL 2919 0.1970
4 VISION ABNORMAL NEONATAL 75 0.1794
5 LEARNING DISORDER 395 0.1636
6 OPISTHOTONUS 127 0.1597
7 SPEECH DISORDER DEVELOPMENTAL 382 0.1331
8 LUPUS VULGARIS 160 0.1270
9 DEEP VEIN THROMBOSIS POSTOPERATIVE 252 0.1258
10 DRUG DIVERSION 664 0.1074
11 X-RAY ABNORMAL 191 0.1067
12 ILL-DEFINED DISORDER 6435 0.1058
13 DEVELOPMENTAL DELAY 900 0.0997
14 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 206 0.0993
15 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 630 0.0969
16 POLYSUBSTANCE ABUSE 60 0.0945
17 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 61 0.0913
18 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 51 0.0909
19 MUSCLE INJURY 741 0.0893
20 DISLOCATION OF VERTEBRA 202 0.0885
21 PORPHYRIA ACUTE 126 0.0878
22 DUODENAL ULCER PERFORATION 652 0.0876
23 C-REACTIVE PROTEIN 81 0.0874
24 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 621 0.0866
25 FACET JOINT SYNDROME 275 0.0844
26 LEARNING DISABILITY 441 0.0827
27 SWOLLEN JOINT COUNT INCREASED 253 0.0793
28 RETINITIS 135 0.0781
29 FOLLICULITIS 777 0.0740
30 ATTENTION DEFICIT HYPERACTIVITY DISORDER 292 0.0693
31 WITHDRAWAL SYNDROME 2895 0.0689
32 OVERDOSE 14269 0.0661
33 HELICOBACTER INFECTION 670 0.0651
34 RHEUMATIC FEVER 287 0.0643
35 TOXICITY TO VARIOUS AGENTS 9581 0.0568
36 PRIMARY SEQUESTRUM 49 0.0541
37 HAND DEFORMITY 689 0.0525
38 OSTEOSCLEROSIS 82 0.0520
39 PERIPHERAL VENOUS DISEASE 212 0.0519
40 BONE EROSION 183 0.0517
41 PEMPHIGUS 642 0.0513
42 PLEURAL FIBROSIS 52 0.0510
43 RHEUMATOID FACTOR POSITIVE 276 0.0477
44 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 50 0.0471
45 LUMBAR RADICULOPATHY 54 0.0466
46 POST-TRAUMATIC STRESS DISORDER 288 0.0429
47 CHOLECYSTITIS CHRONIC 270 0.0403
48 IRRITABLE BOWEL SYNDROME 854 0.0398
49 PERICARDITIS 660 0.0392
50 SUBSTANCE USE DISORDER 125 0.0392
51 C-REACTIVE PROTEIN ABNORMAL 249 0.0388
52 HYPERPARATHYROIDISM SECONDARY 92 0.0367
53 SYNOVITIS 654 0.0362
54 LEFT ATRIAL DILATATION 46 0.0361
55 EXOSTOSIS 316 0.0346
56 GLOSSODYNIA 750 0.0335
57 BURSITIS 402 0.0331
58 NEPHROGENIC ANAEMIA 153 0.0330
59 BILIARY DYSKINESIA 56 0.0330
60 DRUG TOLERANCE DECREASED 91 0.0324
61 MATERNAL EXPOSURE TIMING UNSPECIFIED 121 0.0322
62 KYPHOSIS 56 0.0317
63 INTERVERTEBRAL DISC DEGENERATION 281 0.0303
64 DRUG ABUSE 2511 0.0301
65 OSTEOLYSIS 61 0.0298
66 IMPAIRED HEALING 966 0.0294
67 AUTOIMMUNE DISORDER 280 0.0287
68 PRE-EXISTING CONDITION IMPROVED 179 0.0286
69 DRUG DEPENDENCE 4592 0.0285
70 HYPERCHOLESTEROLAEMIA 275 0.0285
71 ESSENTIAL HYPERTENSION 52 0.0284
72 LUMBAR SPINAL STENOSIS 82 0.0280
73 LIP DRY 246 0.0271
74 DRUG TOLERANCE 137 0.0271
75 BONE LESION 97 0.0269
76 EXPOSED BONE IN JAW 58 0.0267
77 BREAST CANCER STAGE III 171 0.0264
78 SUBSTANCE ABUSE 214 0.0263
79 WALKING AID USER 173 0.0262
80 JOINT RANGE OF MOTION DECREASED 349 0.0260
81 GRIP STRENGTH DECREASED 229 0.0260
82 LIVE BIRTH 217 0.0259
83 FOETAL EXPOSURE DURING PREGNANCY 2104 0.0259
84 WOUND INFECTION 283 0.0258
85 SPINAL OSTEOARTHRITIS 223 0.0254
86 WOUND 705 0.0252
87 THROMBOPHLEBITIS SUPERFICIAL 75 0.0247
88 DRUG ABUSER 152 0.0247
89 GALLBLADDER INJURY 48 0.0246
90 SCIATICA 387 0.0243
91 INADEQUATE ANALGESIA 201 0.0236
92 FIBROMYALGIA 570 0.0234
93 REBOUND ACID HYPERSECRETION 70 0.0231
94 ATELECTASIS 223 0.0231
95 RADICULOPATHY 60 0.0227
96 SPINAL FUSION SURGERY 92 0.0227
97 ACCIDENTAL OVERDOSE 816 0.0223
98 BREAKTHROUGH PAIN 51 0.0220
99 DILATATION VENTRICULAR 46 0.0219
100 AORTIC ARTERIOSCLEROSIS 56 0.0217
101 AUTISM SPECTRUM DISORDER 119 0.0216
102 PLEURITIC PAIN 59 0.0214
103 DISABILITY 419 0.0212
104 SYSTEMIC LUPUS ERYTHEMATOSUS 752 0.0212
105 INTERVERTEBRAL DISC DISORDER 90 0.0211
106 CANCER PAIN 53 0.0207
107 FOOT DEFORMITY 229 0.0206
108 EXCORIATION 52 0.0205
109 OBESITY 322 0.0202
110 EXPOSURE VIA BREAST MILK 78 0.0196
111 PULMONARY INFARCTION 46 0.0194
112 LOWER RESPIRATORY TRACT INFECTION 881 0.0194
113 LEFT VENTRICULAR HYPERTROPHY 82 0.0191
114 LOWER LIMB FRACTURE 365 0.0190
115 INJURY 1334 0.0190
116 DEATH 16300 0.0189
117 DIABETIC NEUROPATHY 93 0.0188
118 HEPATITIS C 226 0.0187
119 SPINAL COLUMN STENOSIS 88 0.0186
120 JOINT DISLOCATION 194 0.0183
121 ARTHROPATHY 1006 0.0181
122 NEPHROGENIC SYSTEMIC FIBROSIS 54 0.0179
123 NIGHT SWEATS 571 0.0177
124 INTERVERTEBRAL DISC PROTRUSION 382 0.0175
125 SCOLIOSIS 108 0.0174
126 NECK INJURY 51 0.0174
127 METASTASES TO SPINE 58 0.0172
128 BLISTER 969 0.0172
129 ECONOMIC PROBLEM 260 0.0171
130 OSTEOARTHRITIS 727 0.0171
131 LUPUS-LIKE SYNDROME 153 0.0169
132 MUSCLE SPASTICITY 207 0.0168
133 DENTAL CARIES 186 0.0168
134 COMPRESSION FRACTURE 90 0.0168
135 LOOSE TOOTH 54 0.0167
136 CONTRAINDICATED PRODUCT ADMINISTERED 507 0.0167
137 CARDIOMEGALY 204 0.0166
138 HIP ARTHROPLASTY 254 0.0166
139 BACK INJURY 178 0.0164
140 ROAD TRAFFIC ACCIDENT 683 0.0163
141 STOMATITIS 988 0.0163
142 SLEEP APNOEA SYNDROME 309 0.0162
143 SPONDYLITIS 58 0.0159
144 END STAGE RENAL DISEASE 286 0.0157
145 DEAFNESS NEUROSENSORY 51 0.0155
146 GASTROINTESTINAL DISORDER 1385 0.0154
147 FLANK PAIN 144 0.0153
148 TRICUSPID VALVE INCOMPETENCE 122 0.0153
149 HYPERLIPIDAEMIA 183 0.0153
150 TYPE 2 DIABETES MELLITUS 513 0.0152
151 PUSTULAR PSORIASIS 52 0.0151
152 BACK DISORDER 246 0.0151
153 ANHEDONIA 396 0.0151
154 KNEE ARTHROPLASTY 317 0.0150
155 PRESCRIBED OVERDOSE 291 0.0150
156 MASTICATION DISORDER 46 0.0150
157 FAILURE TO THRIVE 78 0.0150
158 OSTEOPENIA 226 0.0149
159 DRUG SCREEN POSITIVE 116 0.0147
160 EAR PAIN 282 0.0145
161 LIVER INJURY 356 0.0145
162 DIVERTICULUM 103 0.0145
163 CHOLECYSTITIS ACUTE 82 0.0145
164 ENDOMETRIOSIS 69 0.0145
165 DIVERTICULUM INTESTINAL 63 0.0144
166 PATHOLOGICAL FRACTURE 73 0.0144
167 PERIPHERAL VASCULAR DISORDER 74 0.0143
168 ROTATOR CUFF SYNDROME 184 0.0143
169 PURULENT DISCHARGE 61 0.0143
170 SPINAL COMPRESSION FRACTURE 118 0.0143
171 LUNG INFILTRATION 126 0.0143
172 ANXIETY DISORDER 47 0.0141
173 SPINAL DISORDER 133 0.0140
174 LIGAMENT RUPTURE 62 0.0140
175 SNORING 53 0.0140
176 GALLBLADDER DISORDER 250 0.0140
177 PULMONARY FIBROSIS 268 0.0140
178 THERAPEUTIC PRODUCT EFFECT DECREASED 625 0.0139
179 BONE DISORDER 253 0.0139
180 JOINT EFFUSION 95 0.0138
181 GAIT INABILITY 460 0.0138
182 TOOTH ABSCESS 140 0.0137
183 SINUSITIS 1406 0.0137
184 DISCOMFORT 837 0.0137
185 INFUSION RELATED REACTION 904 0.0136
186 SHOULDER OPERATION 58 0.0136
187 RASH VESICULAR 65 0.0134
188 HAEMORRHAGIC ANAEMIA 59 0.0134
189 ECCHYMOSIS 92 0.0134
190 SPINAL CORD COMPRESSION 52 0.0133
191 UTERINE PERFORATION 113 0.0133
192 MENTAL STATUS CHANGES 370 0.0133
193 HEPATIC ENZYME INCREASED 895 0.0131
194 RED BLOOD CELL SEDIMENTATION RATE INCREASED 145 0.0131
195 HEPATIC CIRRHOSIS 246 0.0131
196 CONTUSION 1257 0.0130
197 FACIAL BONES FRACTURE 47 0.0130
198 DEPRESSION 2958 0.0130
199 BIPOLAR DISORDER 141 0.0130
200 AORTIC VALVE INCOMPETENCE 55 0.0129
201 SPINAL OPERATION 159 0.0129
202 MUSCULOSKELETAL PAIN 676 0.0129
203 TOOTH LOSS 265 0.0128
204 BLOOD CHOLESTEROL INCREASED 593 0.0127
205 ABDOMINAL HERNIA 58 0.0127
206 FAECAL INCONTINENCE 61 0.0127
207 OSTEOMYELITIS 228 0.0126
208 RENAL CYST 100 0.0126
209 CEREBRAL ATROPHY 50 0.0125
210 SWELLING 1173 0.0125
211 MATERNAL EXPOSURE DURING PREGNANCY 1117 0.0125
212 CHRONIC SINUSITIS 47 0.0125
213 DECREASED INTEREST 73 0.0124
214 ARTERIOSCLEROSIS CORONARY ARTERY 82 0.0124
215 MITRAL VALVE INCOMPETENCE 140 0.0124
216 AMNESIA 803 0.0123
217 ONYCHOMYCOSIS 54 0.0123
218 EUPHORIC MOOD 126 0.0123
219 ANKLE FRACTURE 190 0.0123
220 DEEP VEIN THROMBOSIS 795 0.0122
221 PRODUCT ADMINISTRATION INTERRUPTED 96 0.0122
222 WEIGHT FLUCTUATION 127 0.0121
223 MULTIPLE DRUG OVERDOSE 60 0.0121
224 LYMPHOEDEMA 83 0.0120
225 DRUG WITHDRAWAL SYNDROME 1053 0.0120
226 JOINT SWELLING 1438 0.0119
227 CARDIAC MURMUR 103 0.0119
228 NERVE INJURY 132 0.0119
229 RIB FRACTURE 244 0.0119
230 VARICOSE VEIN 61 0.0118
231 RENAL FAILURE CHRONIC 90 0.0117
232 RHINITIS ALLERGIC 52 0.0117
233 CHRONIC KIDNEY DISEASE 887 0.0117
234 DEFORMITY 109 0.0117
235 CONGENITAL ANOMALY 90 0.0116
236 PHYSICAL DISABILITY 51 0.0115
237 DECUBITUS ULCER 94 0.0115
238 TOOTH FRACTURE 127 0.0115
239 TENDERNESS 120 0.0115
240 OSTEOPOROSIS 473 0.0115
241 SYNOVIAL CYST 53 0.0115
242 CHOLELITHIASIS 376 0.0115
243 HYPOVOLAEMIA 67 0.0114
244 SLEEP DISORDER 808 0.0114
245 HIATUS HERNIA 148 0.0114
246 FOOT FRACTURE 216 0.0114
247 CHOLECYSTECTOMY 130 0.0114
248 MULTIPLE MYELOMA 53 0.0114
249 GASTROOESOPHAGEAL REFLUX DISEASE 910 0.0113
250 SOMNAMBULISM 74 0.0113
251 ARTERIOSCLEROSIS 105 0.0111
252 GINGIVITIS 60 0.0111
253 BRAIN INJURY 111 0.0111
254 NEURALGIA 269 0.0111
255 HYPERKERATOSIS 61 0.0110
256 MALNUTRITION 123 0.0110
257 BODY TEMPERATURE INCREASED 222 0.0109
258 RESPIRATORY DISORDER 325 0.0109
259 MUSCULOSKELETAL CHEST PAIN 168 0.0108
260 HAEMORRHOIDS 209 0.0107
261 LUMBAR VERTEBRAL FRACTURE 49 0.0107
262 VITAMIN D DEFICIENCY 104 0.0107
263 HAEMATOCRIT DECREASED 211 0.0106
264 ANXIETY 3025 0.0106
265 EAR INFECTION 282 0.0106
266 MAJOR DEPRESSION 77 0.0105
267 PSORIATIC ARTHROPATHY 426 0.0105
268 LIGAMENT SPRAIN 103 0.0104
269 TOOTH INFECTION 137 0.0104
270 IMPAIRED DRIVING ABILITY 118 0.0104
271 MULTIPLE INJURIES 65 0.0103
272 NERVE COMPRESSION 95 0.0103
273 CONFUSIONAL STATE 1656 0.0102
274 BUNDLE BRANCH BLOCK RIGHT 47 0.0102
275 DYSLIPIDAEMIA 52 0.0102
276 PROTHROMBIN TIME PROLONGED 61 0.0102
277 CARPAL TUNNEL SYNDROME 142 0.0101
278 SPINAL FRACTURE 203 0.0101
279 PERIPHERAL SWELLING 1558 0.0101
280 INFECTION 1463 0.0101
281 UPPER RESPIRATORY TRACT INFECTION 467 0.0101
282 DELIRIUM 348 0.0100
283 LOWER GASTROINTESTINAL HAEMORRHAGE 74 0.0100
284 DYSPHAGIA 949 0.0100
285 MENTAL DISORDER 435 0.0100
286 PULMONARY EMBOLISM 948 0.0100
287 WRONG TECHNIQUE IN DRUG USAGE PROCESS 359 0.0099
288 RHEUMATOID ARTHRITIS 1122 0.0099
289 HYPERAESTHESIA 81 0.0099
290 JAW DISORDER 54 0.0099
291 IRON DEFICIENCY ANAEMIA 91 0.0098
292 OEDEMA 533 0.0098
293 BACK PAIN 2283 0.0098
294 EMPHYSEMA 99 0.0098
295 MYOSITIS 88 0.0098
296 PAIN 6008 0.0098
297 PREGNANCY 195 0.0097
298 ORAL PAIN 217 0.0097
299 PERONEAL NERVE PALSY 55 0.0097
300 SMALL INTESTINAL OBSTRUCTION 119 0.0097
301 EMOTIONAL DISTRESS 1165 0.0096
302 HYDRONEPHROSIS 72 0.0096
303 PULMONARY MASS 143 0.0096
304 HAND FRACTURE 68 0.0096
305 FOOD ALLERGY 74 0.0096
306 NEPHROLITHIASIS 439 0.0096
307 IMPAIRED GASTRIC EMPTYING 130 0.0095
308 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 497 0.0095
309 CRYING 345 0.0095
310 ACUTE RESPIRATORY FAILURE 182 0.0095
311 ASTHMA 1067 0.0094
312 SCAR 161 0.0094
313 BLOOD MAGNESIUM DECREASED 81 0.0094
314 NECK PAIN 521 0.0093
315 JOINT INJURY 199 0.0093
316 TOOTH DISORDER 206 0.0093
317 RESTLESS LEGS SYNDROME 167 0.0092
318 DRUG INTOLERANCE 887 0.0092
319 WRIST FRACTURE 110 0.0092
320 BLOOD CALCIUM DECREASED 103 0.0092
321 OEDEMA PERIPHERAL 1113 0.0091
322 MIGRAINE 867 0.0091
323 CLOSTRIDIUM DIFFICILE COLITIS 96 0.0090
324 SEASONAL ALLERGY 128 0.0090
325 PULMONARY CONGESTION 118 0.0089
326 LUNG DISORDER 438 0.0089
327 ARTHRITIS 702 0.0089
328 BLOOD POTASSIUM DECREASED 268 0.0089
329 ACTIVITIES OF DAILY LIVING IMPAIRED 176 0.0089
330 DRUG TOXICITY 121 0.0089
331 LIVER DISORDER 393 0.0089
332 CHOLECYSTITIS 105 0.0088
333 INCOHERENT 57 0.0088
334 PAIN IN JAW 249 0.0088
335 CROHN'S DISEASE 60 0.0087
336 POST PROCEDURAL COMPLICATION 168 0.0087
337 JOINT STIFFNESS 229 0.0087
338 ABDOMINAL DISCOMFORT 1457 0.0087
339 WHEEZING 515 0.0087
340 CELLULITIS 437 0.0087
341 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 147 0.0086
342 GROIN PAIN 76 0.0086
343 AFFECTIVE DISORDER 68 0.0086
344 RESPIRATORY DEPRESSION 106 0.0086
345 TOOTHACHE 156 0.0086
346 OSTEONECROSIS OF JAW 213 0.0086
347 MUSCULOSKELETAL STIFFNESS 753 0.0086
348 SINUS TACHYCARDIA 122 0.0086
349 QUALITY OF LIFE DECREASED 115 0.0086
350 MUSCULOSKELETAL DISCOMFORT 147 0.0085
351 ANOREXIA 110 0.0085
352 UPPER LIMB FRACTURE 170 0.0085
353 HAIR DISORDER 70 0.0085
354 BLOOD SODIUM DECREASED 160 0.0085
355 MENISCUS INJURY 52 0.0084
356 CHEST PAIN 1564 0.0084
357 DRUG ADMINISTERED AT INAPPROPRIATE SITE 89 0.0084
358 DRY MOUTH 684 0.0084
359 INFUSION SITE SWELLING 53 0.0084
360 DERMATITIS CONTACT 96 0.0084
361 HOSPICE CARE 83 0.0084
362 WHITE BLOOD CELL COUNT INCREASED 322 0.0084
363 HYPOAESTHESIA 1254 0.0084
364 LEFT VENTRICULAR DYSFUNCTION 56 0.0084
365 PRODUCT PRESCRIBING ISSUE 182 0.0083
366 OBSESSIVE-COMPULSIVE DISORDER 67 0.0083
367 METASTASES TO BONE 137 0.0083
368 MOBILITY DECREASED 599 0.0083
369 BLOOD ALBUMIN DECREASED 66 0.0083
370 ULCER HAEMORRHAGE 56 0.0083
371 PREMATURE BABY 249 0.0083
372 RECTAL HAEMORRHAGE 355 0.0083
373 KNEE OPERATION 81 0.0082
374 PELVIC FRACTURE 64 0.0082
375 LOCAL SWELLING 143 0.0082
376 BREAST MASS 55 0.0082
377 FACIAL PAIN 73 0.0082
378 RENAL FAILURE ACUTE 347 0.0082
379 DISTURBANCE IN ATTENTION 441 0.0082
380 LIMB INJURY 222 0.0082
381 INTENTIONAL PRODUCT MISUSE 714 0.0081
382 BODY HEIGHT DECREASED 87 0.0081
383 HAIR COLOUR CHANGES 101 0.0081
384 BRONCHITIS 598 0.0081
385 SURGERY 473 0.0081
386 BREAST CANCER STAGE II 67 0.0080
387 GINGIVAL PAIN 64 0.0080
388 BLOOD TESTOSTERONE DECREASED 55 0.0080
389 MULTIPLE ALLERGIES 63 0.0080
390 RENAL FAILURE 1067 0.0080
391 PSYCHOLOGICAL TRAUMA 69 0.0080
392 WEIGHT INCREASED 1790 0.0080
393 MICTURITION URGENCY 91 0.0080
394 APNOEA 62 0.0080
395 BLADDER DISORDER 79 0.0079
396 CONCUSSION 61 0.0079
397 MASS 110 0.0079
398 CONSTIPATION 1715 0.0079
399 HYSTERECTOMY 68 0.0078
400 RENAL TUBULAR NECROSIS 77 0.0078
401 ABSCESS 125 0.0078
402 LARGE INTESTINE POLYP 54 0.0078
403 LACERATION 73 0.0078
404 SEDATION 203 0.0077
405 DYSURIA 285 0.0077
406 GENERAL SYMPTOM 58 0.0077
407 ULCER 123 0.0077
408 PULMONARY HYPERTENSION 161 0.0077
409 VITAMIN D DECREASED 66 0.0077
410 PARANOIA 133 0.0077
411 NASOPHARYNGITIS 1422 0.0077
412 SENSORY LOSS 62 0.0077
413 POSTOPERATIVE WOUND INFECTION 52 0.0077
414 ABASIA 190 0.0077
415 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 369 0.0077
416 INFLAMMATION 395 0.0076
417 GASTROENTERITIS VIRAL 138 0.0076
418 HYPERHIDROSIS 983 0.0076
419 INSOMNIA 2030 0.0076
420 PROCTALGIA 49 0.0076
421 SKIN ULCER 197 0.0076
422 PANCREATITIS 402 0.0076
423 CORONARY ARTERY DISEASE 230 0.0076
424 VENTRICULAR EXTRASYSTOLES 78 0.0075
425 HEPATIC STEATOSIS 139 0.0075
426 CYST 92 0.0074
427 FEELING DRUNK 55 0.0074
428 INCREASED TENDENCY TO BRUISE 68 0.0074
429 COAGULOPATHY 123 0.0074
430 DEHYDRATION 984 0.0074
431 FREQUENT BOWEL MOVEMENTS 199 0.0074
432 HYPOXIA 259 0.0073
433 LABORATORY TEST ABNORMAL 217 0.0073
434 NOCTURIA 89 0.0073
435 URINARY INCONTINENCE 217 0.0073
436 DYSPEPSIA 719 0.0073
437 INFUSION SITE PAIN 94 0.0073
438 ACCIDENT 87 0.0073
439 MUSCLE STRAIN 63 0.0073
440 COLITIS ISCHAEMIC 49 0.0073
441 HYPERSENSITIVITY 1348 0.0073
442 STAPHYLOCOCCAL INFECTION 239 0.0072
443 GAIT DISTURBANCE 1385 0.0072
444 KIDNEY INFECTION 142 0.0072
445 TOOTH EXTRACTION 90 0.0072
446 BEDRIDDEN 95 0.0072
447 GENERAL PHYSICAL HEALTH DETERIORATION 832 0.0072
448 INTERNATIONAL NORMALISED RATIO INCREASED 205 0.0072
449 MUSCULAR WEAKNESS 815 0.0072
450 DYSPNOEA EXERTIONAL 270 0.0072
451 BLOOD IRON DECREASED 85 0.0072
452 UPPER-AIRWAY COUGH SYNDROME 59 0.0072
453 GASTRITIS 188 0.0071
454 ATRIAL FLUTTER 57 0.0071
455 PROCEDURAL PAIN 198 0.0071
456 NEUROPATHY PERIPHERAL 678 0.0071
457 HYPERTENSION 1506 0.0071
458 SINUS CONGESTION 96 0.0071
459 CARDIOMYOPATHY 105 0.0071
460 INCONTINENCE 75 0.0071
461 ORAL DISORDER 52 0.0071
462 HEAD INJURY 224 0.0071
463 ANGINA UNSTABLE 46 0.0071
464 MEMORY IMPAIRMENT 970 0.0071
465 HAIR TEXTURE ABNORMAL 94 0.0070
466 WEIGHT DECREASED 1959 0.0070
467 IMPAIRED WORK ABILITY 150 0.0070
468 BONE PAIN 411 0.0070
469 ELECTROCARDIOGRAM ABNORMAL 55 0.0070
470 MUSCLE SPASMS 1283 0.0070
471 FALL 2325 0.0070
472 COLD SWEAT 123 0.0070
473 GOUT 125 0.0070
474 ARTHRALGIA 2880 0.0069
475 PANIC ATTACK 252 0.0069
476 ABDOMINAL PAIN 1608 0.0069
477 CARDIO-RESPIRATORY ARREST 289 0.0069
478 LEUKOCYTOSIS 125 0.0069
479 FORMICATION 48 0.0069
480 UNRESPONSIVE TO STIMULI 178 0.0069
481 ABDOMINAL PAIN UPPER 1415 0.0069
482 EATING DISORDER 146 0.0068
483 SICKLE CELL ANAEMIA WITH CRISIS 108 0.0068
484 ILEUS 85 0.0068
485 HYPERSOMNIA 196 0.0068
486 HYPOACUSIS 294 0.0068
487 SEXUAL DYSFUNCTION 80 0.0068
488 SINUS DISORDER 135 0.0068
489 RENAL INJURY 202 0.0068
490 PAIN IN EXTREMITY 2001 0.0068
491 THERMAL BURN 48 0.0068
492 CEREBRAL DISORDER 50 0.0068
493 NODULE 88 0.0067
494 CARDIAC FAILURE CONGESTIVE 540 0.0067
495 MADAROSIS 78 0.0067
496 SKIN LACERATION 73 0.0067
497 INTENTIONAL DRUG MISUSE 140 0.0067
498 CYSTITIS 213 0.0067
499 HERNIA 129 0.0067
500 INFUSION SITE ERYTHEMA 56 0.0066
501 IMMUNODEFICIENCY 99 0.0066
502 POST PROCEDURAL INFECTION 54 0.0066
503 HEPATOMEGALY 65 0.0066
504 SUICIDAL IDEATION 605 0.0066
505 DECREASED APPETITE 1533 0.0066
506 OESOPHAGITIS 72 0.0066
507 TROPONIN INCREASED 50 0.0066
508 ALOPECIA 1288 0.0066
509 RED BLOOD CELL COUNT DECREASED 187 0.0065
510 LOCALISED INFECTION 158 0.0065
511 RESPIRATORY ARREST 180 0.0065
512 FLUID OVERLOAD 95 0.0065
513 VOMITING 3066 0.0065
514 OVARIAN CYST 65 0.0065
515 SKIN LESION 178 0.0065
516 HYPOPHAGIA 165 0.0064
517 SUICIDE ATTEMPT 391 0.0064
518 PERICARDIAL EFFUSION 149 0.0064
519 PELVIC PAIN 117 0.0064
520 PHARMACEUTICAL PRODUCT COMPLAINT 167 0.0064
521 CARDIAC DISORDER 601 0.0064
522 NIGHTMARE 222 0.0064
523 METASTASES TO LUNG 74 0.0064
524 THINKING ABNORMAL 119 0.0064
525 ASTHENIA 2399 0.0064
526 IMPAIRED QUALITY OF LIFE 91 0.0063
527 ENCEPHALOPATHY 155 0.0063
528 AORTIC ANEURYSM 48 0.0063
529 HYPOKALAEMIA 291 0.0063
530 TEMPERATURE INTOLERANCE 65 0.0063
531 PLEURAL EFFUSION 383 0.0063
532 URINE OUTPUT DECREASED 55 0.0063
533 ELECTROLYTE IMBALANCE 73 0.0063
534 DRUG EFFECT DECREASED 337 0.0063
535 THERAPY NON-RESPONDER 281 0.0062
536 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 107 0.0062
537 INTENTIONAL PRODUCT USE ISSUE 546 0.0062
538 FISTULA 70 0.0062
539 BLOOD POTASSIUM INCREASED 101 0.0062
540 URINARY TRACT INFECTION 1060 0.0062
541 ANGER 210 0.0062
542 ARTHROPOD BITE 46 0.0062
543 MOOD SWINGS 196 0.0061
544 DIVERTICULITIS 170 0.0061
545 UNEVALUABLE EVENT 464 0.0061
546 HIP FRACTURE 197 0.0061
547 PHARYNGEAL OEDEMA 94 0.0061
548 HYPERCALCAEMIA 75 0.0061
549 PNEUMONIA 1964 0.0061
550 DRUG USE DISORDER 51 0.0061
551 GENERALISED OEDEMA 75 0.0061
552 LETHARGY 348 0.0060
553 BLOOD ALKALINE PHOSPHATASE INCREASED 150 0.0060
554 FLUID RETENTION 307 0.0060
555 COELIAC DISEASE 59 0.0060
556 SPUTUM DISCOLOURED 57 0.0060
557 SINUS BRADYCARDIA 58 0.0060
558 NEPHROPATHY 56 0.0060
559 TREMOR 994 0.0060
560 BONE LOSS 90 0.0060
561 NAUSEA 4729 0.0060
562 PERIPHERAL COLDNESS 82 0.0060
563 THROMBOSIS 480 0.0060
564 HAEMATEMESIS 151 0.0060
565 DYSARTHRIA 224 0.0059
566 INITIAL INSOMNIA 61 0.0059
567 NAIL DISORDER 52 0.0059
568 EXPOSURE DURING PREGNANCY 369 0.0059
569 FURUNCLE 47 0.0059
570 DYSPNOEA 3355 0.0059
571 FATIGUE 4608 0.0059
572 ANKYLOSING SPONDYLITIS 78 0.0059
573 TENDON RUPTURE 73 0.0059
574 THERAPEUTIC RESPONSE UNEXPECTED 265 0.0059
575 BLOOD URINE PRESENT 112 0.0059
576 MENTAL IMPAIRMENT 143 0.0059
577 BACTERAEMIA 70 0.0059
578 SPINAL PAIN 69 0.0059
579 FEAR 158 0.0059
580 URINARY RETENTION 196 0.0059
581 RETCHING 125 0.0059
582 PARAESTHESIA 920 0.0058
583 RENAL DISORDER 272 0.0058
584 PYREXIA 2013 0.0058
585 PRESCRIBED UNDERDOSE 116 0.0058
586 ATAXIA 69 0.0058
587 TRANSIENT ISCHAEMIC ATTACK 196 0.0058
588 LYMPHADENOPATHY 205 0.0058
589 DYSSTASIA 169 0.0058
590 VISUAL IMPAIRMENT 717 0.0058
591 DIABETES MELLITUS 441 0.0058
592 HAEMATURIA 198 0.0058
593 FEELING JITTERY 110 0.0058
594 ORAL CANDIDIASIS 76 0.0058
595 MEDICATION ERROR 319 0.0057
596 HAEMOGLOBIN DECREASED 589 0.0057
597 PHARYNGITIS STREPTOCOCCAL 62 0.0057
598 ESCHERICHIA INFECTION 47 0.0057
599 HAEMATOMA 148 0.0057
600 FEELING HOT 350 0.0057
601 HEART RATE IRREGULAR 129 0.0057
602 UPPER GASTROINTESTINAL HAEMORRHAGE 96 0.0057
603 PERSONALITY CHANGE 53 0.0057
604 NERVOUSNESS 298 0.0057
605 PRODUCTIVE COUGH 272 0.0057
606 METASTASES TO LIVER 100 0.0057
607 INSURANCE ISSUE 87 0.0057
608 MUSCLE ATROPHY 72 0.0057
609 CONVULSION 325 0.0057
610 MUSCLE DISORDER 46 0.0057
611 BLOOD UREA INCREASED 95 0.0057
612 LOSS OF CONSCIOUSNESS 716 0.0056
613 SOMNOLENCE 1122 0.0056
614 ANAL INCONTINENCE 50 0.0056
615 HAEMOPTYSIS 155 0.0056
616 COORDINATION ABNORMAL 77 0.0055
617 HYPOKINESIA 80 0.0055
618 HEREDITARY ANGIOEDEMA 59 0.0055
619 ACUTE KIDNEY INJURY 841 0.0055
620 TENDONITIS 85 0.0055
621 RESPIRATORY TRACT CONGESTION 87 0.0055
622 FULL BLOOD COUNT DECREASED 110 0.0055
623 ABDOMINAL PAIN LOWER 138 0.0055
624 VENTRICULAR TACHYCARDIA 90 0.0054
625 GASTRIC ULCER 103 0.0054
626 POLLAKIURIA 226 0.0054
627 GRAND MAL CONVULSION 50 0.0054
628 POOR QUALITY SLEEP 116 0.0054
629 ERECTILE DYSFUNCTION 138 0.0054
630 EAR DISCOMFORT 55 0.0054
631 URTICARIA 897 0.0053
632 ORTHOSTATIC HYPOTENSION 93 0.0053
633 RESPIRATORY DISTRESS 147 0.0053
634 BALANCE DISORDER 460 0.0053
635 DIABETES MELLITUS INADEQUATE CONTROL 94 0.0053
636 INTESTINAL OBSTRUCTION 200 0.0053
637 CANDIDA INFECTION 89 0.0053
638 SCAB 60 0.0053
639 COMPLETED SUICIDE 438 0.0053
640 CHILLS 616 0.0052
641 SEPSIS 586 0.0052
642 HEADACHE 3294 0.0052
643 MUSCLE TWITCHING 121 0.0052
644 NO THERAPEUTIC RESPONSE 64 0.0052
645 MUSCLE TIGHTNESS 85 0.0052
646 HERPES ZOSTER 301 0.0052
647 FEELING ABNORMAL 1251 0.0052
648 POOR VENOUS ACCESS 54 0.0052
649 EJECTION FRACTION DECREASED 81 0.0052
650 ANAEMIA 993 0.0052
651 MOTOR DYSFUNCTION 53 0.0052
652 FEMUR FRACTURE 161 0.0052
653 DEVICE RELATED INFECTION 80 0.0052
654 GASTROINTESTINAL HAEMORRHAGE 433 0.0052
655 DIARRHOEA 3340 0.0052
656 PRODUCT ADHESION ISSUE 184 0.0051
657 GASTROENTERITIS 75 0.0051
658 BLOOD PRESSURE INCREASED 785 0.0051
659 TUBULOINTERSTITIAL NEPHRITIS 96 0.0051
660 HYPOMAGNESAEMIA 71 0.0051
661 THIRST 91 0.0051
662 PULMONARY OEDEMA 228 0.0051
663 CLOSTRIDIUM DIFFICILE INFECTION 111 0.0051
664 DIPLOPIA 132 0.0051
665 ATRIAL FIBRILLATION 493 0.0051
666 BURNING SENSATION 355 0.0051
667 BLOOD TRIGLYCERIDES INCREASED 89 0.0050
668 SPLENOMEGALY 59 0.0050
669 PRURITUS 1935 0.0050
670 C-REACTIVE PROTEIN INCREASED 183 0.0050
671 FEELING COLD 140 0.0050
672 DISORIENTATION 199 0.0050
673 ACUTE MYOCARDIAL INFARCTION 148 0.0050
674 GASTRIC DISORDER 172 0.0050
675 FEEDING DISORDER 101 0.0050
676 RESPIRATORY FAILURE 363 0.0050
677 BLOOD PRESSURE SYSTOLIC INCREASED 97 0.0050
678 MUSCULOSKELETAL DISORDER 94 0.0049
679 IMMUNE SYSTEM DISORDER 65 0.0049
680 ASPIRATION 54 0.0049
681 HEART RATE INCREASED 488 0.0049
682 MYOCARDIAL ISCHAEMIA 56 0.0049
683 FLATULENCE 279 0.0049
684 PNEUMOTHORAX 78 0.0049
685 HYPOTHYROIDISM 157 0.0049
686 EMOTIONAL DISORDER 151 0.0049
687 MALAISE 2147 0.0049
688 VISION BLURRED 671 0.0049
689 NEUTROPHIL COUNT INCREASED 50 0.0049
690 BODY TEMPERATURE DECREASED 48 0.0049
691 TRANSFUSION 51 0.0049
692 PRESYNCOPE 118 0.0048
693 BRAIN FOG 76 0.0048
694 DIZZINESS POSTURAL 47 0.0048
695 HALLUCINATION 365 0.0048
696 HOT FLUSH 365 0.0048
697 HYPOAESTHESIA ORAL 73 0.0048
698 DRUG DISPENSING ERROR 74 0.0048
699 DRUG PRESCRIBING ERROR 93 0.0048
700 OXYGEN SATURATION DECREASED 272 0.0048
701 BLOOD PRESSURE DECREASED 321 0.0048
702 BLOOD CREATININE INCREASED 315 0.0048
703 BACTERIAL INFECTION 90 0.0048
704 DECREASED ACTIVITY 52 0.0048
705 THYROID DISORDER 74 0.0048
706 RESPIRATORY TRACT INFECTION 125 0.0048
707 OROPHARYNGEAL PAIN 444 0.0048
708 COLITIS ULCERATIVE 214 0.0048
709 NASAL CONGESTION 281 0.0048
710 ABNORMAL DREAMS 132 0.0048
711 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 339 0.0048
712 PANCREATITIS ACUTE 107 0.0048
713 GINGIVAL BLEEDING 65 0.0048
714 PHARYNGITIS 59 0.0048
715 PARALYSIS 68 0.0047
716 RASH 2068 0.0047
717 SENSORY DISTURBANCE 76 0.0047
718 COLITIS 179 0.0047
719 RENAL PAIN 50 0.0047
720 FRACTURE 89 0.0047
721 TREATMENT FAILURE 389 0.0047
722 DRUG ADMINISTRATION ERROR 144 0.0047
723 ORAL DISCOMFORT 65 0.0047
724 HYPOTENSION 938 0.0047
725 CORONARY ARTERY OCCLUSION 64 0.0047
726 CONDITION AGGRAVATED 1419 0.0047
727 OSTEONECROSIS 153 0.0047
728 DELUSION 72 0.0046
729 GLAUCOMA 89 0.0046
730 NEOPLASM 53 0.0046
731 IRRITABILITY 277 0.0046
732 EYE INFECTION 52 0.0046
733 FUNGAL INFECTION 153 0.0046
734 SPEECH DISORDER 240 0.0046
735 DIZZINESS 2284 0.0046
736 MULTIPLE FRACTURES 75 0.0046
737 SKIN INFECTION 51 0.0045
738 GASTROINTESTINAL PAIN 50 0.0045
739 ABDOMINAL DISTENSION 474 0.0045
740 PLASMA CELL MYELOMA 176 0.0045
741 MOOD ALTERED 123 0.0045
742 BREAST PAIN 48 0.0045
743 SUBDURAL HAEMATOMA 64 0.0045
744 BONE DENSITY DECREASED 140 0.0045
745 INTERNAL HAEMORRHAGE 51 0.0045
746 TINNITUS 205 0.0045
747 RASH PRURITIC 241 0.0044
748 MIDDLE INSOMNIA 83 0.0044
749 AGGRESSION 222 0.0044
750 SKIN DISCOLOURATION 203 0.0044
751 BLOOD PRESSURE FLUCTUATION 106 0.0044
752 SYNCOPE 441 0.0044
753 CATARACT 262 0.0044
754 ANGINA PECTORIS 126 0.0044
755 INFLUENZA LIKE ILLNESS 360 0.0044
756 COGNITIVE DISORDER 204 0.0044
757 THERAPY CESSATION 224 0.0044
758 APPLICATION SITE RASH 60 0.0044
759 CHOKING 85 0.0044
760 BRAIN OEDEMA 55 0.0043
761 BLOOD COUNT ABNORMAL 66 0.0043
762 FAECES DISCOLOURED 94 0.0043
763 MULTIPLE SCLEROSIS RELAPSE 297 0.0043
764 TREATMENT NONCOMPLIANCE 237 0.0043
765 ASPARTATE AMINOTRANSFERASE INCREASED 230 0.0043
766 MULTIPLE SCLEROSIS 207 0.0043
767 CHEST DISCOMFORT 443 0.0043
768 ILLNESS 445 0.0043
769 MOUTH ULCERATION 91 0.0043
770 HAEMATOCHEZIA 238 0.0043
771 PRODUCT SUBSTITUTION ISSUE 248 0.0043
772 SWELLING FACE 280 0.0043
773 LIMB DISCOMFORT 133 0.0043
774 AGITATION 315 0.0043
775 TASTE DISORDER 87 0.0043
776 MYALGIA 728 0.0043
777 HYPERGLYCAEMIA 156 0.0043
778 INFLUENZA 476 0.0043
779 DYSKINESIA 173 0.0043
780 PHOTOPHOBIA 80 0.0042
781 HEMIPARESIS 72 0.0042
782 ASCITES 124 0.0042
783 DEAFNESS 110 0.0042
784 DEPRESSED MOOD 221 0.0042
785 WHITE BLOOD CELL COUNT DECREASED 450 0.0041
786 GLOMERULAR FILTRATION RATE DECREASED 51 0.0041
787 HEPATIC FAILURE 125 0.0041
788 COMA 196 0.0041
789 DRUG DOSE OMISSION 680 0.0041
790 METASTASES TO CENTRAL NERVOUS SYSTEM 53 0.0041
791 COLON CANCER 61 0.0041
792 CENTRAL NERVOUS SYSTEM LESION 56 0.0041
793 MENORRHAGIA 80 0.0041
794 APHASIA 123 0.0041
795 EPISTAXIS 304 0.0041
796 BASAL CELL CARCINOMA 63 0.0040
797 PALPITATIONS 472 0.0040
798 BLOOD PRESSURE ABNORMAL 80 0.0040
799 LYMPHOCYTE COUNT DECREASED 71 0.0040
800 APHONIA 56 0.0040
801 PANCYTOPENIA 224 0.0040
802 SEPTIC SHOCK 174 0.0040
803 MYOCARDIAL INFARCTION 697 0.0040
804 ABNORMAL BEHAVIOUR 158 0.0040
805 VERTIGO 243 0.0040
806 PLATELET COUNT DECREASED 423 0.0040
807 LIVER FUNCTION TEST INCREASED 85 0.0040
808 LIVER FUNCTION TEST ABNORMAL 115 0.0040
809 HEAD DISCOMFORT 70 0.0039
810 NERVOUS SYSTEM DISORDER 123 0.0039
811 PRODUCT QUALITY ISSUE 535 0.0039
812 RESTLESSNESS 144 0.0039
813 MOVEMENT DISORDER 126 0.0039
814 TACHYCARDIA 348 0.0039
815 PRURITUS GENERALISED 84 0.0039
816 DYSPHONIA 227 0.0039
817 CONJUNCTIVITIS 72 0.0039
818 COUGH 1088 0.0039
819 DYSGEUSIA 288 0.0039
820 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 90 0.0039
821 THROMBOCYTOPENIA 430 0.0038
822 HEART RATE DECREASED 135 0.0038
823 INCORRECT DRUG ADMINISTRATION DURATION 108 0.0038
824 CEREBROVASCULAR ACCIDENT 649 0.0038
825 DISEASE PROGRESSION 453 0.0038
826 DRY EYE 191 0.0038
827 RHINORRHOEA 247 0.0038
828 ADVERSE EVENT 352 0.0038
829 CYANOSIS 60 0.0038
830 PARAESTHESIA ORAL 55 0.0038
831 HYPERKALAEMIA 133 0.0038
832 CARDIAC ARREST 313 0.0038
833 ADRENAL INSUFFICIENCY 46 0.0038
834 SKIN DISORDER 126 0.0038
835 LACRIMATION INCREASED 114 0.0038
836 PLATELET COUNT INCREASED 49 0.0038
837 PALLOR 102 0.0037
838 DRUG EFFECT INCOMPLETE 136 0.0037
839 ADVERSE DRUG REACTION 335 0.0037
840 PNEUMONIA ASPIRATION 93 0.0037
841 THROAT IRRITATION 167 0.0037
842 HALLUCINATION, AUDITORY 59 0.0037
843 PRODUCT PHYSICAL ISSUE 74 0.0037
844 MULTI-ORGAN FAILURE 63 0.0036
845 CHROMATURIA 82 0.0036
846 ALANINE AMINOTRANSFERASE INCREASED 222 0.0036
847 PRODUCT USE ISSUE 678 0.0036
848 RASH ERYTHEMATOUS 171 0.0036
849 THROAT TIGHTNESS 96 0.0035
850 HYPOCALCAEMIA 67 0.0035
851 SEROTONIN SYNDROME 68 0.0035
852 NEOPLASM PROGRESSION 123 0.0035
853 HYPONATRAEMIA 199 0.0035
854 SNEEZING 79 0.0035
855 EYE PAIN 198 0.0035
856 VISUAL ACUITY REDUCED 116 0.0035
857 PROSTATIC SPECIFIC ANTIGEN INCREASED 48 0.0035
858 INTENTIONAL DOSE OMISSION 99 0.0035
859 ACUTE RESPIRATORY DISTRESS SYNDROME 61 0.0034
860 HUNGER 48 0.0034
861 DRUG INEFFECTIVE 4538 0.0034
862 DEMENTIA 96 0.0034
863 ORAL HERPES 67 0.0034
864 RASH GENERALISED 88 0.0034
865 PSYCHOTIC DISORDER 100 0.0034
866 HYPOGLYCAEMIA 163 0.0034
867 DEVICE FAILURE 51 0.0033
868 HOSPITALISATION 514 0.0033
869 THERAPEUTIC RESPONSE DECREASED 202 0.0033
870 DEPRESSED LEVEL OF CONSCIOUSNESS 130 0.0033
871 APPLICATION SITE ERYTHEMA 86 0.0033
872 MALIGNANT NEOPLASM PROGRESSION 336 0.0033
873 VIRAL INFECTION 109 0.0033
874 SEIZURE 378 0.0033
875 RASH PAPULAR 73 0.0033
876 DIALYSIS 46 0.0032
877 BLOOD GLUCOSE DECREASED 155 0.0032
878 HAEMORRHAGE 337 0.0032
879 LUNG INFECTION 50 0.0032
880 AGEUSIA 80 0.0032
881 INTENTIONAL OVERDOSE 205 0.0032
882 APPLICATION SITE PRURITUS 72 0.0032
883 LYMPHOMA 49 0.0032
884 ARRHYTHMIA 150 0.0032
885 EYE DISORDER 104 0.0032
886 BLOOD BILIRUBIN INCREASED 85 0.0031
887 INCREASED APPETITE 60 0.0031
888 SWOLLEN TONGUE 98 0.0031
889 THERAPY INTERRUPTED 223 0.0031
890 BLINDNESS 126 0.0031
891 PHOTOSENSITIVITY REACTION 51 0.0031
892 PRODUCT DOSE OMISSION 200 0.0031
893 RASH MACULAR 107 0.0031
894 MUCOSAL INFLAMMATION 80 0.0031
895 RENAL IMPAIRMENT 256 0.0030
896 VAGINAL HAEMORRHAGE 131 0.0030
897 FLUSHING 305 0.0030
898 PROTEINURIA 57 0.0030
899 DIABETIC KETOACIDOSIS 72 0.0030
900 MANIA 49 0.0030
901 EYE SWELLING 110 0.0030
902 LUNG NEOPLASM MALIGNANT 121 0.0029
903 SKIN CANCER 63 0.0029
904 FEBRILE NEUTROPENIA 193 0.0029
905 DERMATITIS 60 0.0029
906 NEOPLASM MALIGNANT 190 0.0028
907 ERYTHEMA 583 0.0028
908 BRADYCARDIA 150 0.0028
909 PSORIASIS 366 0.0028
910 SKIN FISSURES 54 0.0028
911 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 151 0.0027
912 PRODUCT DOSE OMISSION IN ERROR 77 0.0027
913 DEVICE DISLOCATION 118 0.0027
914 CEREBRAL INFARCTION 66 0.0027
915 PNEUMONITIS 73 0.0027
916 METABOLIC ACIDOSIS 84 0.0026
917 LEUKOPENIA 131 0.0026
918 HEPATITIS 67 0.0026
919 BLOOD GLUCOSE INCREASED 489 0.0026
920 MELAENA 57 0.0026
921 NEUTROPHIL COUNT DECREASED 105 0.0026
922 GLYCOSYLATED HAEMOGLOBIN INCREASED 65 0.0026
923 PRODUCT DISPENSING ERROR 56 0.0026
924 SHOCK 59 0.0026
925 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 181 0.0025
926 ERUCTATION 49 0.0025
927 INCORRECT ROUTE OF DRUG ADMINISTRATION 90 0.0025
928 DRUG-INDUCED LIVER INJURY 79 0.0025
929 PRODUCT DOSE OMISSION ISSUE 738 0.0025
930 RASH MACULO-PAPULAR 55 0.0025
931 OFF LABEL USE 2151 0.0025
932 DRUG INTERACTION 386 0.0024
933 INJECTION SITE BRUISING 194 0.0024
934 ANAPHYLACTIC REACTION 132 0.0024
935 SKIN EXFOLIATION 198 0.0023
936 PRODUCT USE IN UNAPPROVED INDICATION 581 0.0023
937 HALLUCINATION, VISUAL 49 0.0023
938 JAUNDICE 62 0.0023
939 RHABDOMYOLYSIS 96 0.0023
940 DRY SKIN 302 0.0023
941 CARDIOVASCULAR DISORDER 57 0.0022
942 TARDIVE DYSKINESIA 63 0.0022
943 LIP SWELLING 74 0.0022
944 BLOOD CREATINE PHOSPHOKINASE INCREASED 63 0.0022
945 OCULAR HYPERAEMIA 103 0.0022
946 DEVICE ISSUE 194 0.0022
947 COVID-19 377 0.0021
948 TRANSAMINASES INCREASED 47 0.0021
949 PRODUCT AVAILABILITY ISSUE 48 0.0021
950 UNDERDOSE 153 0.0021
951 APPLICATION SITE PAIN 46 0.0021
952 NEUTROPENIA 283 0.0021
953 CARDIAC FAILURE 167 0.0021
954 INJECTION SITE URTICARIA 51 0.0021
955 CEREBRAL HAEMORRHAGE 74 0.0021
956 PRODUCT PRESCRIBING ERROR 49 0.0021
957 DRUG EXPOSURE DURING PREGNANCY 67 0.0020
958 INJECTION SITE PAIN 598 0.0019
959 PAIN OF SKIN 52 0.0019
960 INCORRECT DOSE ADMINISTERED 439 0.0019
961 ELECTROCARDIOGRAM QT PROLONGED 69 0.0019
962 EYE IRRITATION 110 0.0019
963 INJECTION SITE RASH 58 0.0019
964 INJECTION SITE PRURITUS 126 0.0019
965 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 334 0.0019
966 INJECTION SITE HAEMORRHAGE 145 0.0018
967 ANGIOEDEMA 78 0.0018
968 MULTIPLE ORGAN DYSFUNCTION SYNDROME 49 0.0017
969 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 349 0.0017
970 EXPIRED PRODUCT ADMINISTERED 57 0.0017
971 LACTIC ACIDOSIS 55 0.0017
972 PANCREATIC CARCINOMA 49 0.0017
973 DEVICE MALFUNCTION 118 0.0017
974 INJECTION SITE ERYTHEMA 206 0.0017
975 INJECTION SITE MASS 61 0.0016
976 THERAPEUTIC RESPONSE SHORTENED 54 0.0016
977 EYE PRURITUS 54 0.0016
978 INJECTION SITE SWELLING 118 0.0015
979 EPILEPSY 46 0.0015
980 INTERSTITIAL LUNG DISEASE 72 0.0015
981 EXTRA DOSE ADMINISTERED 59 0.0015
982 SKIN IRRITATION 65 0.0014
983 DISEASE RECURRENCE 67 0.0014
984 ACNE 101 0.0013
985 DEVICE LEAKAGE 57 0.0013
986 INJECTION SITE REACTION 87 0.0013
987 BREAST CANCER 112 0.0012
988 ECZEMA 58 0.0011
989 SKIN BURNING SENSATION 77 0.0011
990 PROSTATE CANCER 85 0.0011
991 DEVICE DIFFICULT TO USE 53 0.0008
992 NO ADVERSE EVENT 141 0.0008
993 ACCIDENTAL EXPOSURE TO PRODUCT 55 0.0005